Chronic Myelomonocytic Leukemia-1
Information
- Disease name
- Chronic Myelomonocytic Leukemia-1
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01522976 | Active, not recruiting | Phase 2 | Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia | March 1, 2012 | March 7, 2025 |
| NCT03682029 | Active, not recruiting | N/A | Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | November 21, 2017 | September 27, 2025 |
| NCT04734990 | Recruiting | Phase 1/Phase 2 | Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia | July 7, 2021 | September 11, 2025 |
| NCT05038592 | Recruiting | Phase 1/Phase 2 | Tagraxofusp and Decitabine for the Treatment of Chronic Myelomonocytic Leukemia | March 4, 2022 | January 29, 2025 |